A new trading day began on November 17, 2023, with Viking Therapeutics Inc (NASDAQ: VKTX) stock priced at $10.55, up 7.03% from the previous day of trading. During the day, the shares moved up to $11.40 and dropped to $10.51 before settling in for the closing price of $10.53. VKTX’s price has ranged from $3.54 to $25.72 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Meanwhile, its annual earnings per share averaged -3.19%. With a float of $89.36 million, this company’s outstanding shares have now reached $100.03 million.
The extent of productivity of a business whose workforce counts for 21 workers is very important to gauge.
Viking Therapeutics Inc (VKTX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 10.66%, while institutional ownership is 75.56%. The most recent insider transaction that took place on May 16, was worth 1,000,000. In this transaction Director of this company sold 40,000 shares at a rate of $25.00, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 16, when Company’s Director sold 16,000 for $24.00, making the entire transaction worth $384,000. This insider now owns 47,965 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.23 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -39.67. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -2.56% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 28.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
The latest stats from [Viking Therapeutics Inc, VKTX] show that its last 5-days average volume of 2.05 million was inferior to 2.91 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.62%. Additionally, its Average True Range was 0.74.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 34.73%, which indicates a significant decrease from 76.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.26% in the past 14 days, which was higher than the 58.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.34, while its 200-day Moving Average is $15.08. Now, the first resistance to watch is $11.61. This is followed by the second major resistance level at $11.95. The third major resistance level sits at $12.50. If the price goes on to break the first support level at $10.72, it is likely to go to the next support level at $10.17. Assuming the price breaks the second support level, the third support level stands at $9.83.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 1.13 billion, the company has a total of 100,029K Shares Outstanding. Currently, annual sales are 0 K while annual income is -68,870 K. The company’s previous quarter sales were 0 K while its latest quarter income was -22,530 K.